Plenge, Robert M <br/><br/>
Genetic variants that predict response to anti-tumor necrosis factor therapy in rheumatoid arthritis: current challenges and future directions.  [electronic resource] 

 -  Current opinion in rheumatology  Mar 2008 
 - 145-52 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1040-8711 
<br/><br/><label>Standard No.: </label>10.1097/BOR.0b013e3282f5135b  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal--therapeutic use<br/>Arthritis, Rheumatoid--drug therapy<br/>Biomarkers, Pharmacological<br/>Gene Frequency<br/>Humans<br/>Immunologic Factors--pharmacology<br/>Immunosuppressive Agents--pharmacology<br/>Pharmacogenetics<br/>Receptors, Tumor Necrosis Factor--therapeutic use<br/>Tumor Necrosis Factor-alpha--antagonists & inhibitors